{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,17]],"date-time":"2026-06-17T16:06:41Z","timestamp":1781712401329,"version":"3.54.5"},"reference-count":45,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,5,25]],"date-time":"2021-05-25T00:00:00Z","timestamp":1621900800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100002347","name":"Bundesministerium f\u00fcr Bildung und Forschung","doi-asserted-by":"publisher","award":["01GI0925"],"award-info":[{"award-number":["01GI0925"]}],"id":[{"id":"10.13039\/501100002347","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular Metabolism"],"published-print":{"date-parts":[[2021,11]]},"DOI":"10.1016\/j.molmet.2021.101262","type":"journal-article","created":{"date-parts":[[2021,5,31]],"date-time":"2021-05-31T12:22:43Z","timestamp":1622463763000},"page":"101262","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":22,"special_numbering":"C","title":["Hemostatic alterations linked to body fat distribution, fatty liver, and insulin resistance"],"prefix":"10.1016","volume":"53","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5718-1530","authenticated-orcid":false,"given":"Sebastian","family":"H\u00f6rber","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1218-6810","authenticated-orcid":false,"given":"Rainer","family":"Lehmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Norbert","family":"Stefan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J\u00fcrgen","family":"Machann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andreas L.","family":"Birkenfeld","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert","family":"Wagner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin","family":"Heni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hans-Ulrich","family":"H\u00e4ring","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andreas","family":"Fritsche","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andreas","family":"Peter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.molmet.2021.101262_bib1","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1038\/s41574-020-00462-1","article-title":"Global pandemics interconnected - obesity, impaired metabolic health and COVID-19","volume":"17","author":"Stefan","year":"2021","journal-title":"Nature Reviews Endocrinology"},{"issue":"1","key":"10.1016\/j.molmet.2021.101262_bib2","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1038\/s41574-020-00435-4","article-title":"COVID-19 and diabetes mellitus: from pathophysiology to clinical management","volume":"17","author":"Lim","year":"2021","journal-title":"Nature Reviews Endocrinology"},{"issue":"10223","key":"10.1016\/j.molmet.2021.101262_bib3","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1016\/S0140-6736(20)30211-7","article-title":"Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study","volume":"395","author":"Chen","year":"2020","journal-title":"Lancet"},{"issue":"10","key":"10.1016\/j.molmet.2021.101262_bib4","doi-asserted-by":"crossref","DOI":"10.3390\/pathogens9100785","article-title":"Endothelial cell contributions to COVID-19","volume":"9","author":"Oxford","year":"2020","journal-title":"Pathogens"},{"issue":"23","key":"10.1016\/j.molmet.2021.101262_bib5","doi-asserted-by":"crossref","first-page":"2033","DOI":"10.1182\/blood.2020006000","article-title":"COVID-19 and its implications for thrombosis and anticoagulation","volume":"135","author":"Connors","year":"2020","journal-title":"Blood"},{"issue":"10234","key":"10.1016\/j.molmet.2021.101262_bib6","doi-asserted-by":"crossref","first-page":"1417","DOI":"10.1016\/S0140-6736(20)30937-5","article-title":"Endothelial cell infection and endotheliitis in COVID-19","volume":"395","author":"Varga","year":"2020","journal-title":"Lancet"},{"issue":"8","key":"10.1016\/j.molmet.2021.101262_bib7","doi-asserted-by":"crossref","first-page":"1561","DOI":"10.1111\/jth.13369","article-title":"C-reactive protein, obesity, and the risk for arterial and venous thrombosis","volume":"14","author":"Horvei","year":"2016","journal-title":"Journal of Thrombosis and Haemostasis"},{"issue":"4","key":"10.1016\/j.molmet.2021.101262_bib8","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1160\/TH13-01-0075","article-title":"Thrombosis in central obesity and metabolic syndrome: mechanisms and epidemiology","volume":"110","author":"Morange","year":"2013","journal-title":"Thrombosis & Haemostasis"},{"issue":"7121","key":"10.1016\/j.molmet.2021.101262_bib9","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1038\/nature05487","article-title":"Mechanisms linking obesity with cardiovascular disease","volume":"444","author":"Van Gaal","year":"2006","journal-title":"Nature"},{"issue":"8","key":"10.1016\/j.molmet.2021.101262_bib10","doi-asserted-by":"crossref","first-page":"798","DOI":"10.1055\/s-2007-1000372","article-title":"Hemostatic dysfunction associated with endocrine disorders as a major risk factor and cause of human morbidity and mortality: a comprehensive meta-review","volume":"33","author":"Mina","year":"2007","journal-title":"Seminars in Thrombosis and Hemostasis"},{"issue":"9","key":"10.1016\/j.molmet.2021.101262_bib11","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1016\/S2213-8587(19)30084-1","article-title":"Visceral and ectopic fat, atherosclerosis, and cardiometabolic disease: a position statement","volume":"7","author":"Neeland","year":"2019","journal-title":"Lancet Diabetes Endocrinol"},{"issue":"7","key":"10.1016\/j.molmet.2021.101262_bib12","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1016\/S2213-8587(20)30110-8","article-title":"Causes, consequences, and treatment of metabolically unhealthy fat distribution","volume":"8","author":"Stefan","year":"2020","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/j.molmet.2021.101262_bib13","doi-asserted-by":"crossref","first-page":"154317","DOI":"10.1016\/j.metabol.2020.154317","article-title":"The role of visceral adiposity in the severity of COVID-19: highlights from a unicenter cross-sectional pilot study in Germany","volume":"110","author":"Petersen","year":"2020","journal-title":"Metabolism"},{"key":"10.1016\/j.molmet.2021.101262_bib14","doi-asserted-by":"crossref","first-page":"154440","DOI":"10.1016\/j.metabol.2020.154440","article-title":"Visceral fat is associated to the severity of COVID-19","volume":"115","author":"Favre","year":"2021","journal-title":"Metabolism"},{"issue":"3","key":"10.1016\/j.molmet.2021.101262_bib15","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1016\/j.jhep.2016.05.013","article-title":"Non-alcoholic fatty liver disease and risk for incident cardiovascular disease: a meta-analysis","volume":"65","author":"Targher","year":"2016","journal-title":"Journal of Hepatology"},{"key":"10.1016\/j.molmet.2021.101262_bib16","doi-asserted-by":"crossref","DOI":"10.1210\/clinem\/dgab124","article-title":"Lifestyle intervention improves prothrombotic coagulation profile in individuals at high-risk for type 2 diabetes","author":"Horber","year":"2021","journal-title":"The Journal of Cinical Endocrinology and Metabolism"},{"issue":"1","key":"10.1016\/j.molmet.2021.101262_bib17","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1055\/s-0030-1248723","article-title":"Disorders of coagulation and hemostasis in abdominal obesity: emerging role of fatty liver","volume":"36","author":"Targher","year":"2010","journal-title":"Seminars in Thrombosis and Hemostasis"},{"issue":"9","key":"10.1016\/j.molmet.2021.101262_bib18","doi-asserted-by":"crossref","first-page":"1046","DOI":"10.1093\/cvr\/cvx086","article-title":"New insights into the role of adipose tissue in thrombosis","volume":"113","author":"Vilahur","year":"2017","journal-title":"Cardiovascular Research"},{"issue":"9","key":"10.1016\/j.molmet.2021.101262_bib19","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1016\/S2213-8587(16)00082-6","article-title":"Phenotypes of prediabetes and stratification of cardiometabolic risk","volume":"4","author":"Stefan","year":"2016","journal-title":"Lancet Diabetes Endocrinol"},{"issue":"4","key":"10.1016\/j.molmet.2021.101262_bib20","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1160\/TH13-04-0285","article-title":"Ectopic fat: the true culprit linking obesity and cardiovascular disease?","volume":"110","author":"Morelli","year":"2013","journal-title":"Thrombosis & Haemostasis"},{"key":"10.1016\/j.molmet.2021.101262_bib21","series-title":"Risk-stratified lifestyle intervention to prevent type 2 diabetes","author":"Fritsche","year":"2021"},{"issue":"2","key":"10.1016\/j.molmet.2021.101262_bib22","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1002\/jmri.22036","article-title":"Topography mapping of whole body adipose tissue using A fully automated and standardized procedure","volume":"31","author":"Wurslin","year":"2010","journal-title":"Journal of Magnetic Resonance Imaging"},{"issue":"4","key":"10.1016\/j.molmet.2021.101262_bib23","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1002\/jmri.20292","article-title":"Standardized assessment of whole body adipose tissue topography by MRI","volume":"21","author":"Machann","year":"2005","journal-title":"Journal of Magnetic Resonance Imaging"},{"issue":"9","key":"10.1016\/j.molmet.2021.101262_bib24","doi-asserted-by":"crossref","first-page":"1462","DOI":"10.2337\/diacare.22.9.1462","article-title":"Insulin sensitivity indices obtained from oral glucose tolerance testing: comparison with the euglycemic insulin clamp","volume":"22","author":"Matsuda","year":"1999","journal-title":"Diabetes Care"},{"issue":"2","key":"10.1016\/j.molmet.2021.101262_bib25","doi-asserted-by":"crossref","first-page":"E462","DOI":"10.1152\/ajpendo.00064.2004","article-title":"Magnetic resonance spectroscopy to measure hepatic triglyceride content: prevalence of hepatic steatosis in the general population","volume":"288","author":"Szczepaniak","year":"2005","journal-title":"American Journal of Physiology. Endocrinology and Metabolism"},{"issue":"12","key":"10.1016\/j.molmet.2021.101262_bib26","doi-asserted-by":"crossref","first-page":"3678","DOI":"10.1182\/blood.V95.12.3678.012k45_3678_3682","article-title":"High levels of factor IX increase the risk for venous thrombosis","volume":"95","author":"van Hylckama Vlieg","year":"2000","journal-title":"Blood"},{"issue":"8943","key":"10.1016\/j.molmet.2021.101262_bib27","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1016\/S0140-6736(95)90166-3","article-title":"Role of clotting factor VIII in effect of von Willebrand factor on occurrence of deep-vein thrombosis","volume":"345","author":"Koster","year":"1995","journal-title":"Lancet"},{"issue":"1","key":"10.1016\/j.molmet.2021.101262_bib28","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1097\/TA.0000000000001096","article-title":"Adipose tissue location and contribution to postinjury hypercoagulability","volume":"81","author":"Winfield","year":"2016","journal-title":"J\u00a0Trauma Acute Care Surg"},{"issue":"6","key":"10.1016\/j.molmet.2021.101262_bib29","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1097\/00001721-200309000-00009","article-title":"Associations of haemostatic variables with body mass index: a community-based study","volume":"14","author":"Bowles","year":"2003","journal-title":"Blood Coagulation and Fibrinolysis"},{"issue":"5","key":"10.1016\/j.molmet.2021.101262_bib30","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1016\/j.thromres.2008.07.017","article-title":"Activated protein C levels in obesity and weight loss influence","volume":"123","author":"Sola","year":"2009","journal-title":"Thrombosis Research"},{"issue":"11","key":"10.1016\/j.molmet.2021.101262_bib31","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1016\/S2213-8587(14)70032-4","article-title":"Non-alcoholic fatty liver disease as a cause and a consequence of metabolic syndrome","volume":"2","author":"Yki-Jarvinen","year":"2014","journal-title":"Lancet Diabetes Endocrinol"},{"issue":"8","key":"10.1016\/j.molmet.2021.101262_bib32","doi-asserted-by":"crossref","first-page":"1136","DOI":"10.1016\/j.metabol.2015.09.017","article-title":"Non-alcoholic fatty liver disease and risk for cardiovascular disease","volume":"65","author":"Lonardo","year":"2016","journal-title":"Metabolism"},{"issue":"9","key":"10.1016\/j.molmet.2021.101262_bib33","doi-asserted-by":"crossref","first-page":"1691","DOI":"10.1136\/gutjnl-2020-320622","article-title":"NAFLD and increased risk for cardiovascular disease: clinical associations, pathophysiological mechanisms and pharmacological implications","volume":"69","author":"Targher","year":"2020","journal-title":"Gut"},{"issue":"4","key":"10.1016\/j.molmet.2021.101262_bib34","first-page":"571","article-title":"Insulin sensitivity and hemostatic factors in clinically healthy 58-year-old men","volume":"84","author":"Agewall","year":"2000","journal-title":"Thrombosis & Haemostasis"},{"issue":"10","key":"10.1016\/j.molmet.2021.101262_bib35","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1007\/BF03344054","article-title":"Coagulation and fibrinolysis abnormalities in obesity","volume":"25","author":"De Pergola","year":"2002","journal-title":"Journal of Endocrinological Investigation"},{"issue":"1","key":"10.1016\/j.molmet.2021.101262_bib36","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1007\/s11239-018-1744-9","article-title":"Bariatric surgery in morbidly obese individuals affects plasma levels of protein C and thrombomodulin","volume":"47","author":"Rega-Kaun","year":"2019","journal-title":"Journal of Thrombosis and Thrombolysis"},{"issue":"1","key":"10.1016\/j.molmet.2021.101262_bib37","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/j.jhep.2014.03.013","article-title":"Procoagulant imbalance in patients with non-alcoholic fatty liver disease","volume":"61","author":"Tripodi","year":"2014","journal-title":"Journal of Hepatology"},{"issue":"10","key":"10.1016\/j.molmet.2021.101262_bib38","doi-asserted-by":"crossref","first-page":"1036","DOI":"10.2174\/1381612826666200131101553","article-title":"Nonalcoholic fatty liver disease-evidence for a thrombophilic state?","volume":"26","author":"Spinosa","year":"2020","journal-title":"Current Pharmaceutical Design"},{"issue":"37","key":"10.1016\/j.molmet.2021.101262_bib39","doi-asserted-by":"crossref","first-page":"5834","DOI":"10.3748\/wjg.v11.i37.5834","article-title":"Association between thrombotic risk factors and extent of fibrosis in patients with non-alcoholic fatty liver diseases","volume":"11","author":"Assy","year":"2005","journal-title":"World Journal of Gastroenterology"},{"issue":"1","key":"10.1016\/j.molmet.2021.101262_bib40","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1002\/hep.26510","article-title":"Prothrombotic factors in histologically proven nonalcoholic fatty liver disease and nonalcoholic steatohepatitis","volume":"59","author":"Verrijken","year":"2014","journal-title":"Hepatology"},{"issue":"5","key":"10.1016\/j.molmet.2021.101262_bib41","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1016\/j.jhep.2009.06.023","article-title":"Thrombotic risk factors and liver histologic lesions in non-alcoholic fatty liver disease","volume":"51","author":"Papatheodoridis","year":"2009","journal-title":"Journal of Hepatology"},{"issue":"2","key":"10.1016\/j.molmet.2021.101262_bib42","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1111\/j.1478-3231.2010.02375.x","article-title":"Increased coagulation factor VIII, IX, XI and XII activities in non-alcoholic fatty liver disease","volume":"31","author":"Kotronen","year":"2011","journal-title":"Liver International"},{"issue":"5","key":"10.1016\/j.molmet.2021.101262_bib43","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1136\/gut.2004.060251","article-title":"Elevated plasma protein C levels correlate with the presence of fatty liver (NASH and NAFLD)","volume":"54","author":"Assy","year":"2005","journal-title":"Gut"},{"issue":"12","key":"10.1016\/j.molmet.2021.101262_bib44","doi-asserted-by":"crossref","first-page":"1461","DOI":"10.1038\/ng.257","article-title":"Genetic variation in PNPLA3 confers susceptibility to nonalcoholic fatty liver disease","volume":"40","author":"Romeo","year":"2008","journal-title":"Nature Genetics"},{"issue":"4","key":"10.1016\/j.molmet.2021.101262_bib45","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1038\/ng.2901","article-title":"Exome-wide association study identifies a TM6SF2 variant that confers susceptibility to nonalcoholic fatty liver disease","volume":"46","author":"Kozlitina","year":"2014","journal-title":"Nature Genetics"}],"container-title":["Molecular Metabolism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2212877821001071?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2212877821001071?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:32:38Z","timestamp":1761957158000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2212877821001071"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,11]]},"references-count":45,"alternative-id":["S2212877821001071"],"URL":"https:\/\/doi.org\/10.1016\/j.molmet.2021.101262","relation":{},"ISSN":["2212-8778"],"issn-type":[{"value":"2212-8778","type":"print"}],"subject":[],"published":{"date-parts":[[2021,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Hemostatic alterations linked to body fat distribution, fatty liver, and insulin resistance","name":"articletitle","label":"Article Title"},{"value":"Molecular Metabolism","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.molmet.2021.101262","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 The Authors. Published by Elsevier GmbH.","name":"copyright","label":"Copyright"}],"article-number":"101262"}}